Nabil Chehab, Lung Cancer Medical Franchise Head at AstraZeneca, shared on LinkedIn:
“Lung cancer can affect anyone with lungs.
And yet, the stigma surrounding it and a lack of awareness can mean patients receive a diagnosis too late.
Thankfully, for Emily, a non-smoker living with lung cancer, the story was different. She had access to the right tests, patient navigation support programs and a tailored care plan. I hope for the same for anyone who is at risk of lung cancer.
No one should face barriers when seeking diagnostic answers. Proud that AstraZeneca is elevating patient stories like these during Lung Cancer Awareness Month. I hope stories like Emily’s can challenge outdated assumptions, highlight the value of patient navigation and help change the story of lung cancer – because it is in our hands.
You can also read:
- Nabil Chehab։ Preventive Lung Cancer Screening Through AstraZeneca’s LungHealth, Unified Program
- Lung Cancer in Nonsmoking Individuals: A Distinct Clinical Profile
